An ablation system and device for treating HOCM using nanosecond pulsed electric field technology

Through the precise puncture and adjustment of nanosecond pulse electric field technology, the limitations and safety problems of traditional methods on the central cavity and apical area of ​​the heart cavity in HOCM treatment are solved, achieving more efficient and safe treatment effects, and reducing the importance of structures risk of injury.

CN118557273BActive Publication Date: 2024-11-19HANGZHOUREADY BIOLOGICAL TECH CO LTD
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202411036877.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-19
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

In traditional treatment of hypertrophic obstructive cardiomyopathy (HOCM), radiofrequency ablation and other methods have limitations in treating the central and apical areas of the heart cavity, which may endanger the coronary artery and surrounding important structures, resulting in limited treatment safety and effectiveness.

Method used

Using nanosecond pulse electric field technology, the precise puncture and nanosecond pulse release of electrode needles is realized through the positioning and guidance module, the advance and retreat needle module, the pulse release module and the ultrasonic display module, and the pulse parameters are adjusted according to the preset pulse parameters and real-time impedance detection. Reduce the risk of damage to normal myocardial tissue and coronary artery.

Benefits of technology

It improves the safety and effectiveness of HOCM treatment, can effectively ablate areas that are not accessible to traditional methods, reduces the risk of damage to important structures, and customizes personalized treatment plans based on each patient's physiological condition.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118557273B_ABST
    Figure CN118557273B_ABST
Patent Text Reader

Abstract

The present invention is applicable to the field of medical devices, and provides an ablation system and device for treating HOCM using nanosecond pulsed electric fields. In this system, after the electrode needle is pushed to the target lesion location by the positioning and guidance module and the needle advance and retreat module, the nanosecond pulse generator is instructed to send a nanosecond pulse, and the nanosecond pulse is transmitted to the target lesion location through the electrode needle connected to the nanosecond pulse generator. This solves the problem that radiofrequency ablation or other cold and hot ablation methods will cause irreversible cold and hot damage or mechanical damage to the blood vessels or nerves in the hypertrophic area of ​​the ventricular wall in the middle and apical areas of the heart chamber. In particular, the hypertrophy in the middle and apical areas of the heart chamber will aggravate the damage to the heart function when the myocardial segment reaches 15mm or thicker. The use of nanosecond pulsed electric fields and impedance adaptive release of energy further improves the effect and safety of the treatment, and is also more suitable for different forms of hypertrophic obstructive cardiomyopathy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of medical devices, and in particular to an ablation system and device for treating HOCM using nanosecond pulsed electric field technology. Background Art

[0002] Hypertrophic obstructive cardiomyopathy (HOCM) is a common inherited heart disease characterized by abnormal thickening of the myocardium, especially in the ventricular septum region. This thickening may lead to reduced ventricular filling capacity, reduced cardiac output, and may cause arrhythmias. Traditional treatments include drug management and surgical interventions, while emerging minimally invasive surgical methods, such as percutaneous intramyocardial septal radiofrequency ablation (PIMSRA), can also effectively relieve symptoms and relieve left ventricular outflow tract obstruction. However, the ventricular morphology and structure of HOCM patients are diverse, including ventricular septal hypertrophy, mid-cardiac hypertrophy, and apical hypertrophy. Although PIMSRA is effective in resolving ventricular septal hypertrophy, it has some limitations in dealing with ventricular wall hypertrophy in the mid-cardiac and apical regions. Cold and hot ablation methods such as radiofrequency ablation endanger the coronary arteries and surrounding important structures, thus limiting their application to mid-cardiac hypertrophy and apical hypertrophy. Summary of the invention

[0003] In view of this, the present application provides an ablation system and device for treating HOCM using nanosecond pulsed electric field technology to reduce the risk of damage to important structures such as normal myocardial tissue and coronary arteries around the target lesion during treatment, thereby improving the effectiveness and safety of treatment.

[0004] In a first aspect, the present application provides an ablation system for treating HOCM using nanosecond pulsed electric field technology, the system comprising a positioning and guiding module, a needle advancement and withdrawal module, a pulse release module, and an ultrasound display module;

[0005] The needle insertion and withdrawal module is used to push the electrode needle to the target position when it is determined that the needle needs to be inserted, and to remove the electrode needle from the target position when it is determined that the needle needs to be withdrawn;

[0006] The positioning and guiding module is used to perform ventricular septal decompression according to the guidance of thoracic echocardiography, and puncture the apex of the heart with the electrode needle;

[0007] The pulse release module is used to determine that when the electrode needle reaches the target position, it instructs the electrode needle to release a nanosecond pulse according to preset pulse parameters, and the pulse parameters include electric field strength, pulse frequency, and pulse width;

[0008] The ultrasound display module is used to monitor the target position in real time through ultrasound equipment, determine whether the effect of this pulse ablation reaches a preset target, and end the treatment when it is determined that the preset target is reached.

[0009] Optionally, the system further includes a detection and adjustment module;

[0010] The detection and adjustment module is used to release a microcurrent to detect the first impedance value of the target position before the pulse release module instructs the electrode needle to release a nanosecond pulse, and release a nanosecond pulse for ablation according to a preset pulse parameter;

[0011] After releasing a preset number of nanosecond pulses, releasing microcurrent again to detect a second impedance value at the target position, and determining an impedance change amplitude according to the first impedance value and the second impedance value;

[0012] Determine and adjust pulse parameters according to the second impedance value and the impedance change amplitude, and then release nanosecond pulses according to the adjusted pulse parameters;

[0013] Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulse according to the adjusted pulse parameters until the ultrasound display module determines that the effect of this pulse ablation reaches the preset target.

[0014] Optionally, the needle advancing and retracting module pushes the electrode needle to the target position including:

[0015] The puncture position is confirmed by the conditions of the left and right ventricles and the ventricular septum in the apical four-chamber view before the operation, and the electrode needle is pushed through the puncture position to reach the target position.

[0016] Optionally, the electrode needle adopts a single-needle bipolar design and is connected to a nanosecond pulse generator to transmit nanosecond pulses to the target area;

[0017] The positive and negative electrodes and an insulator are placed at the head end of the electrode needle electrode, and a triangular needle design and an annular convex dot matrix design are adopted.

[0018] Optionally, the ultrasound display module determines whether the effect of the current pulse ablation reaches a preset target, including:

[0019] It is determined on the echocardiogram whether the fixed area around the target position appears as an echo-free area or a hypoechoic area. If so, it is determined that the effect of this pulse ablation reaches the preset target.

[0020] In a second aspect, the present application provides an ablation device for treating HOCM using nanosecond pulsed electric field technology, the device comprising:

[0021] The puncture unit is used to confirm the puncture position according to the situation in the apical four-chamber view before the operation, perform ventricular septal decompression under the guidance of transthoracic echocardiography, and push the electrode needle to puncture the puncture position to reach the target position;

[0022] A pulse release unit, used to release nanosecond pulses according to preset pulse parameters, wherein the pulse parameters include electric field intensity, pulse frequency, and pulse width;

[0023] The effect determination unit is used to determine whether the fixed area around the target position is an echo-free area or a low-echo area. If it is determined, it is determined that the effect of this pulse ablation reaches the preset target, and the electrode needle is removed from the target position.

[0024] Optionally, the device further comprises:

[0025] An adjusting unit, configured to release a microcurrent to detect a first impedance value of the target position before releasing a nanosecond pulse according to preset pulse parameters, and release a microcurrent again to detect a second impedance value of the target position after releasing the nanosecond pulse according to preset pulse parameters, and determine an impedance change amplitude according to the first impedance value and the second impedance value;

[0026] Determine and adjust pulse parameters according to the second impedance value and the impedance change amplitude, and then release nanosecond pulses according to the adjusted pulse parameters;

[0027] Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulse according to the adjusted pulse parameters until it is determined that the effect of this pulse ablation reaches the preset target.

[0028] In the embodiment provided in the present application, after the system pushes the electrode needle to the target lesion position through the positioning and guidance module and the needle advance and retreat module, it instructs the nanosecond pulse generator to send a nanosecond pulse, and transmits the nanosecond pulse to the target lesion position through the electrode needle connected to the nanosecond pulse generator. Since radiofrequency ablation or other methods may cause irreversible thermal damage or mechanical damage to the blood vessels or nerves in the area, this system can achieve ablation treatment of areas that cannot be reached by conventional ablation or surgery, thereby reducing the risk of damage to important structures such as normal myocardial tissue and coronary arteries around the target lesion position during HOCM treatment, and improving the effect and safety of treatment.

[0029] Furthermore, the detection module detects the impedance value of the target area through the released microcurrent, and automatically adjusts the pulse parameters according to the impedance value or automatically ends the treatment when the preset range is reached. It can customize personalized treatment plans according to the unique physiological conditions of each patient and prevent overtreatment or misoperation. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 A system module diagram provided for an embodiment of the present application;

[0031] Figure 2 This is a diagram of the device structure provided in an embodiment of the present application. DETAILED DESCRIPTION

[0032] Exemplary embodiments will be described in detail herein, examples of which are shown in the accompanying drawings. When the following description refers to the drawings, the same numbers in different drawings represent the same or similar elements unless otherwise indicated. The implementations described in the following exemplary embodiments do not represent all implementations consistent with the present application. Instead, they are merely examples of devices and methods consistent with some aspects of the present application as detailed in the appended claims.

[0033] The terms used in this application are for the purpose of describing specific embodiments only and are not intended to limit this application. The singular forms of "a", "said" and "the" used in this application and the appended claims are also intended to include plural forms unless the context clearly indicates other meanings. It should also be understood that the term "and / or" used herein refers to and includes any or all possible combinations of one or more associated listed items.

[0034] It should be understood that although the terms first, second, third, etc. may be used in the present application to describe various information, these information should not be limited to these terms. These terms are only used to distinguish the same type of information from each other. For example, without departing from the scope of the present application, the first information may also be referred to as the second information, and similarly, the second information may also be referred to as the first information. Depending on the context, the word "if" as used herein may be interpreted as "at the time of" or "when" or "in response to determining".

[0035] The technical solution of the present application is described in detail with specific embodiments below. The following specific embodiments can be combined with each other, and the same or similar concepts or processes may not be described in detail in some embodiments.

[0036] like Figure 1 As shown, it is a system module diagram of an ablation system for treating HOCM using nanosecond pulsed electric field technology provided by the present application. The system includes: a positioning and guiding module, a needle advancement and retraction module, a pulse release module, and an ultrasound display module.

[0037] The functions of each module are described below:

[0038] 1. Needle insertion and withdrawal module. This module is used to push the electrode needle to the target position when it is determined that the needle needs to be inserted, and to remove the electrode needle from the target position when it is determined that the needle needs to be withdrawn. The puncture position can be confirmed based on the situation of the left and right ventricles and the ventricular septum in the apical four-chamber view before the operation, and the electrode needle is pushed through the puncture position to reach the target lesion position. After reaching the target position, it can also be determined whether the electrode needle is in sufficient contact with the myocardial hypertrophy area at the target lesion position. If the contact is not sufficient, the electrode needle can be fine-tuned at the target lesion position to make it in sufficient contact. When it is determined that the contact is sufficient, it can be determined that the needle insertion is completed.

[0039] The electrode needle of this module adopts a single-needle bipolar design, which is connected to a nanosecond pulse generator to transmit nanosecond pulses to the target area. The positive and negative electrodes and insulators are placed at the head end of the electrode needle to solve the problem of the difficulty of arranging two electrode needles in conventional surgery, making the operation easier and reducing the trauma of the patient. The head end of the electrode adopts a triangular needle design and a ring-shaped convex dot matrix design, which makes the electrode needle not only have good guidance, but also can reduce tissue damage during the needle insertion and withdrawal process, and can enhance the imaging effect under ultrasound imaging.

[0040] 2. Positioning and guidance module. This module is used to perform ventricular septal decompression under the guidance of thoracic echocardiography, and to puncture the apex of the heart with the electrode needle. The puncture position can be confirmed by the situation of the left and right ventricles and the ventricular septum in the apical four-chamber view before the operation, and the electrode needle is pushed through the puncture position to reach the target position. During the puncture process, the safety of the puncture can be improved by ventricular septal decompression.

[0041] 3. Release pulse module. This module is used to determine when the electrode needle reaches the target area, and instruct the electrode needle to release nanosecond pulses according to preset pulse parameters to achieve coagulation and ablation of myocardial cells. Pulse parameters include electric field strength, pulse frequency, and pulse width. Since nanosecond pulses mainly act on the cell membrane and organelle membrane of myocardial cells, resulting in instability of the potential inside and outside the cells, nanoscale pores are formed on the cell membrane, ultimately causing cell coagulation and death. Therefore, the mechanism of action of nanosecond pulses does not have a direct impact on the vascular structure, thereby improving the safety of the operation.

[0042] In this module, the electric field strength can be set according to different scenarios. For example, the electric field thresholds of myocardial cells and vascular smooth muscle cells are different. Myocardial cells have a lower electric field threshold, while vascular smooth muscle cells have a higher electric field threshold. By setting the electric field strength to be higher than the electric field threshold of myocardial cells and lower than the electric field threshold of vascular smooth muscle cells, it is possible to achieve lower damage to vascular smooth muscle cells during ablation treatment, thereby not affecting the structure of the ventricular septal branches or apical vessels, and instead focusing the ablation target mainly on the myocardial cells in the ablation target area.

[0043] 4. Ultrasound display module. This module is used to monitor the fixed area around the target position in real time through ultrasound equipment to determine whether the effect of this pulse ablation reaches the preset target.

[0044] In another embodiment, the system further includes a detection module.

[0045] This module is used to release microcurrent to detect the first impedance value of the target position before the pulse release module instructs the electrode needle to release the nanosecond pulse, and then release the nanosecond pulse for ablation according to the preset pulse parameters;

[0046] After releasing a preset number of nanosecond pulses, releasing microcurrent again to detect a second impedance value at the target position, and determining an impedance change amplitude according to the first impedance value and the second impedance value;

[0047] Determine and adjust pulse parameters according to the second impedance value and the impedance change amplitude, and then release nanosecond pulses according to the adjusted pulse parameters;

[0048] Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulse according to the adjusted pulse parameters until the ultrasound display module determines that the effect of this pulse ablation reaches the preset target.

[0049] In this embodiment, before treating the target patient, the system presets multiple impedance ranges according to the impedance value, and each impedance range contains multiple pulse parameter combinations. These parameters are determined after the dose-effect relationship is verified using patient-specific data during the research and development phase, such as changes in voltage and number of pulses.

[0050] During ablation treatment, a weak current is first sent into the target patient's body through a highly sensitive electrode to measure the change in electrical impedance when the current passes through the myocardium. This measurement can monitor myocardial function and blood circulation in real time and generate a cardiac electrical impedance map to determine the patient's impedance value before treatment, which is the first impedance value mentioned above.

[0051] After releasing one or several preset groups of nanosecond pulses according to the preset pulse parameters, a weak current continues to be sent into the target patient's body to determine the impedance value after treatment, that is, the second impedance value mentioned above.

[0052] The impedance value after treatment can be used to determine the corresponding impedance range. The impedance value before and after treatment is used to determine the impedance change amplitude caused by this ablation treatment, and the pulse parameter combination within the impedance range is determined based on the impedance change amplitude. The larger the impedance change amplitude, the smaller the voltage matching voltage. This allows the key parameters to be locked based on the impedance value change, and the pulse parameter combination to be quickly determined to ensure that the parameters are selected within the preset safety threshold. It also allows the customization of personalized treatment plans based on each patient's unique physiological condition to prevent overtreatment or misoperation.

[0053] Exemplarily, it is assumed that the preset impedance ranges and the pulse parameter combinations within each impedance range are shown in the following table.

[0054] Impedance Range (Ohms) Voltage (kV) Pulse width (nanoseconds) Number of pulses >1000(high impedance) 25,26,27,28,29,30 300,350,400,450,500,550 600,650,700,800,850,900 500-1000 (medium impedance) 20,21,22,23,24,25 200,250,300,350,400,450 300,350,400,450,500,600 <500(low impedance) 10,12,14,16,18,20 100,150,200,250,300,350 100,140,180,220,260,300

[0055] The pulse parameters in each range in the above table can be divided into 6 groups from low to high. When the impedance value of the target patient before the operation is 2000, it drops to 1000 after releasing several groups of nanosecond pulses. Then, the corresponding resistance range is determined to be medium impedance according to the impedance value. Then, according to the impedance values ​​before and after treatment, the impedance change amplitude is determined to be (2000-1000) / 2000*100%=50%. Pre-set multiple impedance change amplitude intervals to match the corresponding pulse parameters. For example, [45%-55%] matches the first group, [35%-44%] matches the second group, [25%-34%] matches the third group, and so on. It can be determined that the target patient should adjust the pulse parameters to the first group of pulse parameters within the medium impedance range, that is, voltage 20kV, pulse width 200 nanoseconds, and number of pulses 300. If the impedance values ​​of another target patient before and after treatment are 1500 and 1000 respectively, then although the impedance range of this target patient is still medium impedance, since the impedance change amplitude is (1500-1000) / 1500*100%=33.3%, the pulse parameters of this target patient should be adjusted to the third group within the medium impedance range, that is, voltage 22kV, pulse width 300 nanoseconds, and pulse number 400.

[0056] In this embodiment, the pulse parameters are automatically adjusted by the impedance value or the treatment is automatically terminated when the preset interval is reached, so that a personalized treatment plan can be customized according to the unique physiological condition of each patient to prevent overtreatment or misoperation.

[0057] So far, completed Figure 1 Description of the system modules shown.

[0058] In this system, after the electrode needle is pushed to the target lesion position through the positioning and guidance module and the needle advance and retreat module, the nanosecond pulse generator is instructed to send a nanosecond pulse, and the nanosecond pulse is transmitted to the target lesion position through the electrode needle connected to the nanosecond pulse generator. Since radiofrequency ablation or other methods may cause irreversible thermal damage or mechanical damage to the blood vessels or nerves in the area, this system can achieve ablation treatment of areas that cannot be reached by conventional ablation or surgery, thereby reducing the risk of damage to important structures such as normal myocardial tissue and coronary arteries around the target lesion position during HOCM treatment, and improving the effect and safety of treatment.

[0059] Furthermore, the detection module detects the impedance value of the target area through the released microcurrent, and then automatically adjusts the pulse parameters based on the impedance value, so as to customize the personalized treatment plan according to the unique physiological condition of each patient and prevent overtreatment or misoperation.

[0060] like Figure 2 As shown, the present application also provides an ablation device for treating HOCM using nanosecond pulsed electric field technology, the device comprising:

[0061] The puncture unit 201 is used to confirm the puncture position according to the situation in the apical four-chamber view before the operation, perform ventricular septal decompression under the guidance of transthoracic echocardiography, and push the electrode needle to puncture the puncture position to reach the target position;

[0062] A pulse release unit 202, used to release nanosecond pulses according to preset pulse parameters, wherein the pulse parameters include electric field intensity, pulse frequency, and pulse width;

[0063] The effect determination unit 203 is used to determine whether the fixed area around the target position is an echo-free area or a low-echo area. If it is determined, it is determined that the effect of this pulse ablation reaches the preset target, and the electrode needle is removed from the target position.

[0064] In another embodiment, the apparatus further comprises:

[0065] The adjustment unit 204 is used to release a microcurrent to detect a first impedance value of the target position before releasing the nanosecond pulse according to the preset pulse parameters, and release the microcurrent again to detect a second impedance value of the target position after releasing the nanosecond pulse according to the preset pulse parameters, and determine the impedance change amplitude according to the first impedance value and the second impedance value;

[0066] Determine and adjust pulse parameters according to the second impedance value and the impedance change amplitude, and then release nanosecond pulses according to the adjusted pulse parameters;

[0067] Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulse according to the adjusted pulse parameters until it is determined that the effect of this pulse ablation reaches the preset target.

[0068] In this embodiment, an ablation system for treating HOCM using nanosecond pulsed electric field technology is provided, and based on the system, an ablation device for treating HOCM using nanosecond pulsed electric field technology is provided. Through the above system and device, the risk of damage to important structures such as normal myocardial tissue and coronary arteries around the target lesion position during HOCM treatment can be reduced, thereby improving the effect and safety of treatment.

[0069] In addition, in the above-mentioned example implementation of the ablation device for treating HOCM using nanosecond pulsed electric field technology, the logical division of each program module is only an example. In actual application, the above-mentioned functions can be assigned to different program modules as needed, for example, for the configuration requirements of the corresponding hardware or the convenience of software implementation. That is, the internal structure of the ablation device for treating HOCM using nanosecond pulsed electric field technology is divided into different program modules to complete all or part of the functions described above.

[0070] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present application shall be included in the scope of protection of the present application.

Claims

1. An ablation system for treating HOCM using nanosecond pulsed electric field technology, characterized in that: The system includes a needle advancing and retracting module, a positioning and guiding module, a pulse releasing module, an ultrasonic display module and a detection and adjustment module; The needle insertion and withdrawal module is used to push the electrode needle to the target position when it is determined that the needle needs to be inserted, and to remove the electrode needle from the target position when it is determined that the needle needs to be withdrawn; The positioning and guiding module is used to perform ventricular septal decompression according to the guidance of thoracic echocardiography, and puncture the apex of the heart with the electrode needle; The pulse release module is used to determine that when the electrode needle reaches the target position, it instructs the electrode needle to release a nanosecond pulse according to preset pulse parameters, and the pulse parameters include electric field strength, pulse frequency, and pulse width; The ultrasound display module is used to monitor the target position in real time through ultrasound equipment, determine whether the effect of the pulse ablation reaches the preset target, and end the treatment when it is determined that the preset target is reached; The detection and adjustment module is used to release a microcurrent to detect the first impedance value of the target position before the pulse release module instructs the electrode needle to release a nanosecond pulse, and then release a nanosecond pulse for ablation according to a preset pulse parameter; After releasing a preset number of nanosecond pulses, releasing microcurrent again to detect a second impedance value at the target position, and determining an impedance change amplitude according to the first impedance value and the second impedance value; Before treatment, multiple impedance ranges are preset according to the impedance value, each impedance range contains multiple pulse parameter combinations, and multiple impedance change amplitude intervals are pre-set to match the corresponding pulse parameter combinations respectively; Firstly, determining a corresponding impedance range by using the second impedance value, then determining and adjusting a pulse parameter combination within the corresponding impedance range according to the impedance change amplitude, and then releasing a nanosecond pulse according to the adjusted pulse parameters; Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulses according to the adjusted pulse parameters until the ultrasound display module determines that the effect of this pulse ablation reaches the preset target.

2. The system according to claim 1, characterized in that The needle advancing and retracting module pushes the electrode needle to the target position, including: The puncture position is confirmed by the conditions of the left and right ventricles and the ventricular septum in the apical four-chamber view before the operation, and the electrode needle is pushed through the puncture position to reach the target position.

3. The system according to claim 1, characterized in that The electrode needle adopts a single-needle bipolar design and is connected to a nanosecond pulse generator to transmit nanosecond pulses to the target area; The positive and negative electrodes and an insulator are placed at the head end of the electrode needle electrode, and a triangular needle design and an annular convex dot matrix design are adopted.

4. The system according to claim 1, characterized in that The ultrasound display module determines whether the effect of the pulse ablation reaches the preset target by: It is determined on the echocardiogram whether the fixed area around the target position appears as an echo-free area or a hypoechoic area. If so, it is determined that the effect of this pulse ablation reaches the preset target.

5. An ablation device for treating HOCM using nanosecond pulsed electric field technology, characterized in that: The device comprises: The puncture unit is used to confirm the puncture position according to the situation in the apical four-chamber view before the operation, perform ventricular septal decompression under the guidance of transthoracic echocardiography, and push the electrode needle to puncture the puncture position to reach the target position; A pulse release unit, used to release nanosecond pulses according to preset pulse parameters, wherein the pulse parameters include electric field intensity, pulse frequency, and pulse width; An effect determination unit, used to determine whether a fixed area around the target position is an echo-free area or a hypoechoic area. If so, it is determined that the effect of the pulse ablation reaches a preset target, and the electrode needle is removed from the target position; An adjusting unit, configured to release a microcurrent to detect a first impedance value of the target position before releasing a nanosecond pulse according to preset pulse parameters, and release a microcurrent again to detect a second impedance value of the target position after releasing the nanosecond pulse according to preset pulse parameters, and determine an impedance change amplitude according to the first impedance value and the second impedance value; Before treatment, multiple impedance ranges are preset according to the impedance value, each impedance range contains multiple pulse parameter combinations, and multiple impedance change amplitude intervals are pre-set to match the corresponding pulse parameter combinations respectively; Firstly, determining a corresponding impedance range by using the second impedance value, then determining and adjusting a pulse parameter combination within the corresponding impedance range according to the impedance change amplitude, and then releasing a nanosecond pulse according to the adjusted pulse parameters; Repeat the steps of releasing microcurrent to detect impedance value, determining impedance change amplitude and adjusting pulse parameters, and releasing nanosecond pulse according to the adjusted pulse parameters until it is determined that the effect of this pulse ablation reaches the preset target.

Citation Information

Patent Citations

  • Low-voltage impedance check pulse generator

    CN109922862A

  • Electrosurgical adaptive energy control system and control method

    CN110495945A

  • Microwave ablation probe with radiofrequency impedance sensing

    CN112566576A

  • Ablation operation prompting method, electronic device and computer readable storage medium

    CN112842514A

  • High intensity focused ultrasound apparatus

    CN211911724U